🎉 M&A multiples are live!
Check it out!

Ajanta Pharma Valuation Multiples

Discover revenue and EBITDA valuation multiples for Ajanta Pharma and similar public comparables like Pharming, Julphar, and Vivoryon Therapeutics.

Ajanta Pharma Overview

About Ajanta Pharma

Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a presence while generating the vast majority of its revenue in India. The company aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, creams, injectables, capsules, liquids, and lotion. The company's manufacturing plants are located in India.


Founded

1979

HQ

India
Employees

7.8K+

Financials

LTM Revenue $539M

LTM EBITDA $151M

EV

$3.6B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Ajanta Pharma Financials

Ajanta Pharma has a last 12-month revenue of $539M and a last 12-month EBITDA of $151M.

In the most recent fiscal year, Ajanta Pharma achieved revenue of $483M and an EBITDA of $146M.

Ajanta Pharma expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Ajanta Pharma valuation multiples based on analyst estimates

Ajanta Pharma P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $431M $483M XXX XXX XXX
Gross Profit $278M $301M XXX XXX XXX
Gross Margin 65% 62% XXX XXX XXX
EBITDA $102M $146M XXX XXX XXX
EBITDA Margin 24% 30% XXX XXX XXX
Net Profit $82.8M $68.3M XXX XXX XXX
Net Margin 19% 14% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Ajanta Pharma Stock Performance

As of April 15, 2025, Ajanta Pharma's stock price is INR 2567 (or $30).

Ajanta Pharma has current market cap of INR 321B (or $3.7B), and EV of INR 313B (or $3.6B).

See Ajanta Pharma trading valuation data

Ajanta Pharma Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$3.6B $3.7B XXX XXX XXX XXX $0.89

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Ajanta Pharma Valuation Multiples

As of April 15, 2025, Ajanta Pharma has market cap of $3.7B and EV of $3.6B.

Ajanta Pharma's trades at 6.8x LTM EV/Revenue multiple, and 24.1x LTM EBITDA.

Analysts estimate Ajanta Pharma's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Ajanta Pharma and 10K+ public comps

Ajanta Pharma Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $3.6B XXX XXX XXX
EV/Revenue 7.0x XXX XXX XXX
EV/EBITDA 24.4x XXX XXX XXX
P/E 35.6x XXX XXX XXX
P/E/Growth 2.2x XXX XXX XXX
EV/FCF 41.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Ajanta Pharma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Ajanta Pharma Valuation Multiples

Ajanta Pharma's NTM/LTM revenue growth is 13%

Ajanta Pharma's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $30K for the same period.

Over next 12 months, Ajanta Pharma's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Ajanta Pharma's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Ajanta Pharma and other 10K+ public comps

Ajanta Pharma Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 12% XXX XXX XXX XXX
EBITDA Margin 29% XXX XXX XXX XXX
EBITDA Growth 42% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 41% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $30K XXX XXX XXX XXX
S&M Expenses to Revenue 6% XXX XXX XXX XXX
G&A Expenses to Revenue 3% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 48% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Ajanta Pharma Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Ajanta Pharma M&A and Investment Activity

Ajanta Pharma acquired  XXX companies to date.

Last acquisition by Ajanta Pharma was  XXXXXXXX, XXXXX XXXXX XXXXXX . Ajanta Pharma acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Ajanta Pharma

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Ajanta Pharma

When was Ajanta Pharma founded? Ajanta Pharma was founded in 1979.
Where is Ajanta Pharma headquartered? Ajanta Pharma is headquartered in India.
How many employees does Ajanta Pharma have? As of today, Ajanta Pharma has 7.8K+ employees.
Is Ajanta Pharma publicy listed? Yes, Ajanta Pharma is a public company listed on BOM.
What is the stock symbol of Ajanta Pharma? Ajanta Pharma trades under 532331 ticker.
When did Ajanta Pharma go public? Ajanta Pharma went public in 2000.
Who are competitors of Ajanta Pharma? Similar companies to Ajanta Pharma include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Ajanta Pharma? Ajanta Pharma's current market cap is $3.7B
What is the current revenue of Ajanta Pharma? Ajanta Pharma's last 12-month revenue is $539M.
What is the current EBITDA of Ajanta Pharma? Ajanta Pharma's last 12-month EBITDA is $151M.
What is the current EV/Revenue multiple of Ajanta Pharma? Current revenue multiple of Ajanta Pharma is 6.8x.
What is the current EV/EBITDA multiple of Ajanta Pharma? Current EBITDA multiple of Ajanta Pharma is 24.1x.
What is the current revenue growth of Ajanta Pharma? Ajanta Pharma revenue growth between 2023 and 2024 was 12%.
Is Ajanta Pharma profitable? Yes, Ajanta Pharma is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.